NICE has rejected a new blood cancer drug, Yescarta, which is for the treatment of non-Hodgkin lymphoma, for NHS use due to the drug being too expensive.
Tag: nonHodgkin
Latest World News. Find every day short and brief information composed of titles and subtitles and continue reading if interested.
